CLOPIDOGREL
Active substance: clopidogrel
TABLET · CLOPIDOGREL 300 mg/1
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- CLOPIDOGREL · 300 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 93 |
|
| EU 34 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e07-7e78-ad4a-ff0e3326eb5c,01a120c3-2e43-7f02-8736-57bba43b9c87,01a120c3-2e77-7181-b41d-9f14529c3925,01a120c3-2fe3-799b-8224-bdb47d475809,01a120c3-3571-746c-9870-c37dc9f513fa;count=63 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-9884-7d7c-9174-13cd50d12474,01a12091-79f2-7278-ae46-7095ad70ff50;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 31722-759
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 31722-759 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-759 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-759 · Verified 2026-10-09 · open in source